fbpx

Meet Betty – Early Innovation Programs Lead

Early Innovation Programs Lead Betty Zhang oversees MedTech Actuator’s early innovation programs — MedTech Actuator Origin and Menzies Scholarship and Fellowship for researchers innovating in MedTech, HealthTech and BioTech.

As a recent graduate from the University of Melbourne with a Bachelor of Science (Chancellor’s Scholar) in Biotechnology (specialising in Immunology), Betty brings her passion for innovation and the desire to bridge the gap between academia and industry to the role. Her passion for biomedical science started in high school, where she had the opportunity to work in research laboratories across Victoria. Betty was the first Australian scholar in the Clark Scholars high school program where she got a chance to conduct 8 weeks of neuroscience research at Texas Tech University. 

Back in 2018, Betty was also selected as the inaugural Graeme Clark Oration Young Woman Ambassador and successfully organised the first high school neuroscience conference for over 130 students. Betty’s passion for science continued throughout her university years, where she worked as a research assistant at the Walter and Eliza Hall Institute, the Disability Officer Bearer in the University of Melbourne Student Union and as a Fundamental Equities Analyst for biotechnology stocks at Churchill Asset Management.

Discovering her passion for innovation and the desire to bridge the gap between academia and industry she took a management role rather than pursuing her ambition to become a clinician-scientist. In her role as Early Innovation Programs Lead, Betty can realise her passion as the role straddles the intersection of so many fields that she is passionate about. She is responsible for leading innovation workshops across Australia to provide actionable advice for researchers and clinicians interested in commercialisation.

I hope to combine my passion for science, mentoring and finance, especially in leveraging Australia’s capabilities in biomedical innovation”.

Through her role, Betty will be working at the grassroots level of innovation where she will get an opportunity to witness the foundational translation moment for researchers and clinicians to become entrepreneurs.

I am inspired by the collaborative energy of the MedTech Actuator team and the broader community of foundational partners and collaborators. Everyone is so enthusiastic and optimistic about the opportunities for leveraging Australia’s world-class research capabilities to transform human health”, says Betty.

Looking to the future, Betty is excited about the growth of the MedTech industry in Australia and the increasing focus on diversity and inclusion. 

“I am excited about the future of the MedTech Actuator and the broader ecosystem. With the recent growth in the industry and the increasing interest from investors, I am confident that we will see more innovation and growth in the coming years. It is essential that we create an environment that is supportive and inclusive for everyone, and I look forward to contributing to this effort”, says Betty.

Outside of work, Betty co-founded the Melbourne Bioinnovation Student Initiative (MBSI) to support young innovators and entrepreneurs to build multidisciplinary project teams to solve unmet needs in healthcare. She contributed to the executive management of the delivery of projects spanning digital health, AI, synthetic biology and medical devices. As a CEO at MBSI, she hopes to create a community of students interested in applying their skills to create positive change and implement real-world solutions.

We are thrilled to have Betty on our team and look forward to seeing the impact she will make on the MedTech industry in Australia.

Meet our team

More on how the MedTech Actuator team is supporting Asia Pacific’s next wave of health innovators – meet: 

IWD 2023: Cracking the Code

In celebration of International Women’s Day 2023, UN Women Australia announced the theme for this year is “Cracking the Code: Innovation for a gender equal future”. This theme emphasises the crucial role that innovative ideas, inclusive technologies, and accessible education can play in the fight against discrimination and marginalisation of women across the globe. At MedTech Actuator we believe that by championing equality for all women in STEM, we can accelerate progress towards a gender-equal future. 

In conversation with two leading female Medtech entrepreneurs in Australia – Julie Von Grum Director of CROW Clinical and April van der Kamp, CEO and Co-Founder, of DFU Solutions – we uncovered their experiences, and challenges, as female founders in healthcare innovation. They share their insights on the importance of innovation for a gender-equal future and how MedTech Actuator is working to bridge the gap for female and diverse founders in the  pursuit of entrepreneurship and impact. 

Inspired by market opportunity and research commercialisation to become an entrepreneur

Julie – My journey began as a clinical engineer in the US, working in the medical device field. I moved into the clinical trial phase and gained exposure to the industry at the ground level. Over time, I worked with various startups and eventually established a team of field clinical engineers servicing Medtech startups in Australia. We saw an opportunity to bridge the gap between Medtech startups and CROs and started Crow Clinical. It took some time to establish our quality management system and expertise in clinical operations, but we are now a standalone, full-service CRO supporting Medtech devices. My journey has been organic and has required hard work and commitment to achieve our goals.

April – I was inspired to become an entrepreneur and start my own startup, DFU Solutions because of the need for better treatments for diabetic foot ulcers. My grandfather battled with the condition, which ultimately led to his passing. I wanted to make a difference in this space and bridge the gap between research and commercialisation to get solutions to the market. When I was introduced to a senior supervisor from my PhD, Peter Speck who wanted to develop technology for diabetic foot ulcers, we decided to do a startup. We got into the MedTech Actuator accelerator program, which made it all the more real for us. Ultimately, it was the sadness and strong connection to the people affected by this condition that drove me to become an entrepreneur.

Facing challenges and overcoming them

Julie – As a woman in the medical device industry, I’ve faced challenges throughout my career. Women establishing companies face unique challenges, especially in male-dominated industries like mine. There’s a lack of mentorship, and you often have to work harder to prove yourself. This is not unique to our industry, and I’m encouraged to see changes happening, such as increased female representation on corporate boards. It’s important to embrace diversity in terms of sexes, as it brings different strengths and approaches to problem-solving. While progress has been made, we still have a way to go, especially in terms of equal representation in the medical device industry. I hope to make a difference by mentoring and encouraging others, like April, and leveraging the network of support available. Despite the challenges, I’m inspired by the potential for a more diverse and inclusive future.

April – When I first considered pursuing a PhD and starting a business at the same time, some questioned whether I was capable of handling both. This hurtful comment made me question whether I could pursue my goals. Women are often held to a higher standard than men in many industries, and it can be frustrating to be judged solely based on gender. However, I have learned to take criticism with a grain of salt and use it as a point of reflection to improve myself. Surrounding yourself with supportive people and not letting negative comments bring you down is key. Ultimately, facing challenges is part of the journey, but with perseverance and faith in yourself, you can succeed.

Navigating Difficult Situations in Research and Business

April – We had a difficult situation where certain people’s roles in my PhD were changing and it caused a lot of anxiety and stress. It’s something that a lot of women have gone through in research environments but it’s difficult to speak out because of the fear of repercussions. Dealing with difficult people who could potentially cause drama made us unsure whether to speak up or not. However, we realised that getting out of the situation would make things more streamlined and make us feel more confident and comfortable in our position. Talking to other women who have gone through similar situations helped us make the decision to remove those people from our projects. It was a difficult decision because of the fear of consequences, but we realised that taking care of our mental health and progress was more important.

Julie – Making decisions in business always comes with some downsides, but it’s part of the course. It’s natural to sometimes struggle with decisions that we make, but we have to keep moving forward and hang on for the ride.

Incorporating Diversity and Inclusion in Company Culture and Decision-Making

Julie – While our leadership team is predominantly female, we value diversity and inclusivity in our organisation. Our COO happens to be male, and we do not discriminate based on any background. It’s all about finding the right person for the job. Currently, we have an equal number of male and female field clinical engineers, which happened by chance. I find it interesting that there tend to be more women in CRA roles, just like how there used to be more female teachers and nurses. However, I’m encouraged to see more female leaders and physicians within the healthcare industry. The gender gap is closing in many industries, but there is still work to be done. For example, I’m pleasantly surprised to see female electricians and builders breaking gender stereotypes. It’s important to acknowledge physical differences between genders and work to people’s strengths. Our organisation strives to be all-encompassing, ensuring that the focus is on the individual and their abilities, rather than their background or gender. We match the right person to the task at hand.

April – It’s important to emphasise that the right person for the job should always be the priority, regardless of gender or any other background. Discrimination based on gender or assumptions about maternity leave or safety concerns should never be used as reasons not to hire someone. All input and ideas should be taken into consideration, and decisions should be based on expertise and qualifications, rather than stereotyping or biases. When hiring, it’s important to look at a candidate’s fit for the role based on their skills and experience, rather than their gender or any other background. It’s crucial to avoid dismissing anyone as a potential employee based on their gender or orientation. In short, the focus should always be on finding the right person for the job and valuing everyone’s input equally.

Empowering Women and Promoting Gender Equality through entrepreneurship

Julie – Crow Clinical would like to continue to support initiatives like the MedTech Actuator Female Founder’s Award and continue our role in mentorship. We welcome the opportunity to offer guidance to those who may benefit from it. In the past, I have had the opportunity to speak to university audiences about the roles that women can pursue, particularly as field clinical engineers, which have traditionally been male-dominated in the US. I hope to continue doing so to encourage more women to explore the many career options available to them in this industry. Our goal is to help as many people as we can, and we believe that mentorship and education are crucial components of achieving this goal.

April – As the face and CEO of DFU Solutions, I often find myself in the limelight. I believe that this visibility helps to break the stereotype that a CEO should be male. Having more diversity and representation is important, just like in the case of people assuming that a scientist is male. To further promote this, I have joined an awesome group, the Women in Science and Engineering Club, which aims to engage with more people within science and engineering. Through this group, I share my experiences and network to encourage others to pursue their ideas and dreams in STEM. It is common for women to feel disconnected in STEM, and this group is a great way to connect with other women who are making a difference in their respective industries. I also use this platform to encourage students to explore various career options and not to limit themselves to research. We strive to engage with people and show them the broader network of women who are making significant contributions to the industry.

Expanding Your Network Beyond Local Communities and Promoting Women in STEM

Julie – Networking is a crucial aspect of success in any industry, and I believe it’s important to expand beyond just your local community and explore international organisations and conferences to meet with other professionals. As a member of various organisations, including those focused on women in science, I understand the value of subgroups within the industry particularly those focused on women in science, which can help connect people with similar expertise. Creating awareness is important, and organisations should acknowledge and promote women in these roles to encourage and support them in STEM fields.

Prioritising self-care and mental health

Julie – I feel fortunate to live near the ocean. It’s an important part of my routine and it keeps me connected to the land, which is a spiritual place for me. Maintaining personal boundaries is crucial for my mental health because it’s easy to overwork myself when I’m passionate about my business. However, self-discipline is necessary to prevent burnout and create a sustainable long-term strategy. At some point, you’ll no longer be a startup, and you need to establish yourself for the long term.

April – I see a counsellor every two months to have a sounding board, someone to talk to about feeling burnt out or overwhelmed. It’s helpful to have outside tips, like designated crying times or designated days off. I had glandular fever, which was a spanner in the works, but I’m slowly getting back to my routine of going to the gym in the morning, trying to sleep and wake up on time, and pursuing hobbies like gardening. Hobbies are important for mental health, and having a plant or pet to care for can be therapeutic to decompress after a long day of work. I used to work on Sundays, but I realised I needed time to myself, so I stopped. Spending quality time with family and friends is also important.

Creating impact for communities through their work

Julie – As a clinical research organisation, we have different roles we can play with different organisations, and sometimes we pull in resources from other places due to our network. However, I find that the projects we are most proud of are the ones where we are more active and involved, and this seems to result in a smart and smooth project with fewer issues. Within our industry, there are many ways to approach a project, and I believe it’s about doing things with integrity and within our regulatory framework. I am proud of our organisation because they are responsive and can change to accommodate the needs of the client.

There are projects in particular that I consider to be success stories because of the alliance we formed with the client. We fully understood what they wanted to achieve, embraced it, and were flexible enough to adjust our protocols or procedures to best suit their needs. It’s not about enforcing our own standard operating procedures on them but rather about finding the best way to accomplish their goals within the regulatory framework. Overall, I think these projects were successful because we were involved from the beginning and worked closely with the client to achieve their desired outcomes.

April – One of my most rewarding projects has been the ongoing project at DFU Solutions. When we started out, we didn’t think we would get this far, but I’m proud of how much progress we’ve made in less than a year. Going through the MedTech Actuator Accelerator program taught me the importance of learning what you don’t know and not being afraid of it. It has allowed me to gain a deeper understanding of regulations, reimbursement, and other important aspects of the business. Setting up the business itself was a learning experience, with behind-the-scenes tasks I never would have considered before.

This project is special because of the potential impact it could have. By developing a product that could revolutionise treatment for Staphylococcus Aureus infections in remote communities, we could make a real difference in people’s lives. I’m excited to see how our work on isolating phages for my PhD could translate into this project as well. The idea of making a difference is what drives me forward. Ultimately, I believe that access to proper standards of care should not be a privilege, but a right for everyone, and this project is a step towards making that a reality.

Female Leaders and Mentors in STEM: Finding Support and Inspiration

Julie – I find political figures like Julia Gillard and Geraldine Kearney, very inspiring as well as my own team. It’s important to surround yourself with like-minded individuals who have integrity and share the same expectations of behaviour. Even competitors can be mentors and sounding boards if you share a philosophy of doing the right thing. I’m fortunate to have female business leaders who support me and are not trying to tear me down. However, I acknowledge that women can be competitive with each other to prove themselves, which can create challenges in the industry. That’s why it’s crucial to find women who are collaborative and supportive rather than competitive. I admire Julia Gillard’s altruism and look for similar characteristics in female leaders. Ultimately, we need to find the right people to encourage us and vice versa, so we can all grow and develop in this industry together.

April – In my current setting, we recently welcomed a new lab assistant, Dr Felisa Adams, who has been an incredible mentor and support system for me. Her experience and willingness to help have been invaluable in my growth as a researcher. It’s refreshing to have someone who is not competitive but rather collaborative, especially since competitiveness is prevalent in the academic world. Another supervisor, Belinda Martin, has also been a great mentor and advocate for women in STEM. The support and guidance I have received from these female leaders have been inspiring and motivating.

I believe that it’s important to have female leaders who embody altruism and strive to make a difference. Angelina Jolie, for instance, is someone who inspires me with her dedication to supporting refugees. It’s important to have leaders who bring people up with them rather than stepping on them to get ahead. Unfortunately, not everyone embodies this altruistic quality, but I’m grateful to be working with women who are committed to supporting and guiding each other.

Being in the MedTech Actuator program has been an incredible experience, and seeing women pitch their ideas at the demo day was amazing. Meeting other women in the field and feeling the energy and inspiration they bring is truly motivating. It’s great to see so many powerhouses making strides in STEM, and it encourages me to keep going.

Advice for future Women entrepreneurs

April – If you have the will, just do it. Don’t let one person’s opinion stop you. Ask for feedback from multiple people to create a larger data set on which to base your decisions. If the idea has been validated and you are willing to put in the time and effort, go for it. However, if it requires a significant financial investment, consider it carefully.

Julie – While having the will is important, it is crucial to have a well-researched plan in place to ensure success. This plan should include details about the competitive environment, steps to get established over a specific period of time, and a financial plan that is realistic. It is also important to have a dependable team or network in place to support you. By doing so, you can shift rocks more easily and have people to call upon for advice. Looking at the bigger picture, it’s not just about helping one company, but about growing the entire industry. For example, Australia could benefit from being on the map for medical device development, and we need to export our services more. By helping April’s company, we can help the industry as a whole as you know there are a lot of people waving the flag out there as well for us, like Global Victoria, Austrade and we have delegates going over as a part of trade missions and these kinds of activities. 

The MedTech Actuator actively fosters and encourages active participation across all its programs with diversity and inclusion at all levels regardless of race, ethnicity, age, gender, religion, sexual orientation, gender identity, gender expression, disability, economic status and other diverse backgrounds. 

Stay in the loop by signing up for news and updates below, and follow us on LinkedIn and Twitter



SoundEye: Enhancing Healthcare Safety with Sound Recognition and LiDAR Technology

SoundEye is a MedTech startup that aims to provide safety monitoring and peace of mind for the community by utilizing cutting-edge sound recognition and LiDAR technology. The inspiration behind SoundEye comes from the personal experience of Dr Tan Yeow Kee, CEO, SoundEye, whose mother-in-law fell in the hospital and took more than 30 minutes for the nurse to attend to her. Inspired by this incident, SoundEye has collaborated with hospitals and nursing homes to develop LASSO, a device capable of detecting falls and abnormal sounds such as screaming and preventing falls by detecting bed-exit.

One of the biggest challenges faced by SoundEye during the initial development of LASSO was the lack of public datasets available to train the algorithm. However, SoundEye overcame this challenge by collecting real-world data and partnering with hospitals and nursing homes to co-develop LASSO. Despite the added challenge of the COVID-19 pandemic, SoundEye’s focus on technology that benefits the community garnered trust and success, leading to partnerships for LASSO’s development.

SoundEye’s LASSO device integrates seamlessly with existing healthcare systems and offers numerous benefits to both healthcare providers and patients. Singapore, like many other countries, faces healthcare staff shortages, and monitoring an entire COVID-19 community care facility can be a major challenge. LASSO is capable of monitoring washrooms and bed-wards around the clock, removing the need for time-consuming patrols. LASSO enhances safety monitoring by automatically triggering alerts, which can be verified within seconds by watching a short video clip on the mobile application. This not only saves time but also ensures that healthcare staff can attend to urgent matters promptly.

SoundEye’s LASSO device installed in the healthcare facility

In addition to providing safety monitoring in healthcare facilities, SoundEye is also exploring other potential applications of its technology. For instance, it could be used in homes to monitor elderly or disabled family members, providing peace of mind to caregivers who may not always be able to be present.

SoundEye’s experience with the MedTech Actuator Global Navigator Australia

SoundEye recently participated in the MedTech Actuator Global Navigator program, hoping to gain a better understanding of the Australian healthcare and aged-care market and devise a go-to-market strategy.

MedTech Actuator Global Navigator Australia is an intensive innovation program that facilitates a smooth and accelerated connection for growth stage health Startups from Singapore to access the Australian Market. Australia is one of Asia-Pacific’s fastest-growing startup ecosystems. In 2021, Australian BioTech/MedTech startups raised over A$500 million in capital – the 5th largest sector in Australia. 

The Global Navigator experience over the past year, helped SoundEye achieve several milestones, including signing NDAs with two Australian listed companies. The company is currently integrating its solutions with its partners’ back-end systems and working towards real-world deployment. This success is a direct result of the insights and connections gained through the MedTech Actuator Global Navigator program, which provided SoundEye with the opportunity to meet with influential companies and key industry figures.

The MedTech Actuator Global Navigator program provided an invaluable opportunity to connect with mentors and advisors who share a deep passion for utilizing technology to benefit communities. The connections established through this program proved to be extremely valuable, as the MedTech Actuator team’s extensive knowledge of the Australian market and their expansive network provided us with the resources and support necessary to drive our mission forward”, Dr Tan Yeow Kee, CEO, SoundEye.

Looking ahead, SoundEye’s future goals include market expansion to Australia and Japan in the healthcare, aged-care, and surveillance markets. The company plans to achieve this by building upon its success in Singapore and leveraging its partnerships and collaborations with key industry players. With its innovative technology and commitment to serving communities, SoundEye is well-positioned to make a significant impact in the medical technology space.

Dr Tan Yeow Kee, CEO, SoundEye presenting Lasso at the SWITCH Slingshot 2022 conference in Singapore.

The MedTech Actuator Global Navigator program has been instrumental in SoundEye’s success, providing the company with the tools, insights, and connections needed to achieve its goals. SoundEye highly recommends the program to other startups in the medical technology space looking to expand into new markets and make a meaningful impact in the industry.

Applications are now open for MedTech Actuator Global Navigator Perth

Immerse your startup into Perth’s health innovation ecosystem.

MedTech Actuator Global Navigator Perth 2023 is an intensive growth-stage innovation program that enables healthcare startups to enter and explore the Australian Market through Perth.

Perth is situated in a timezone shared with around 60% of the world’s population making it an ideal location to run a business. Perth’s government has also invested over 10 billion in building infrastructure in Perth to transform it into a world-class knowledge and health hub. 

MedTech Actuator Global Navigator Perth is looking for passionate founders and startups to grow their ventures and transform global healthcare. Apply today!





InflaMed: Personalised care for chronic inflammation

In recent years, there has been a growing focus on the importance of personalised, proactive care for those living with chronic inflammatory conditions. MedTech Actuator startup, InflaMed is at the forefront of this movement, prioritising proactive care using personalised data and insights to guide shared decision-making and improve care for those living with chronic conditions like allergies, eczema, and asthma.

The idea for InflaMed came about when the founders Mari Robert and Alan Robert’s daughter routinely broke out with highly irritating eczema. As parents, Mari and Alan wanted to track the various chemicals she was exposed to,  as well as record her diet to identify any patterns that could be contributing to her eczema flare-ups and triggering inflammation episodes. Using her background as a software developer, Mari created an application to collect and organise this data while providing helpful resources for other parents. Now, InflaMed is expanding to serve a wider community, offering more sophisticated capabilities and ongoing support.

The driving force behind InflaMed is a deep personal understanding of the impact that chronic inflammatory conditions can have on the quality of life. The founders know from experience that a one-size-fits-all approach is not enough and that there is a need to focus on the root causes of these conditions. This is why they are dedicated to creating a platform that prioritises personalised care and encourages collaboration between patients and healthcare providers.

Experiencing over a decade, firsthand, the fluctuating severity of chronic eczema and the contribution it has to a lower quality of life for all of us. Combined with the stress and anxiety you face as a parent, I am fully driven to make this work”, Mari Robert, Founder & CEO, InflaMed.

The founders recognise that the role of clinicians is crucial to the success of the platform, so they have made sure to consult with a range of healthcare providers at every stage of the process. They are thrilled to have recently added several key advisors to their team, including  Dr Ellen Paton (GP), Dr Sonika Tyagi  (Data Science and AI advisor), and Dr Maida Affan (Digital Health Brand Advisor).

InflaMed advises any early-stage startup to first build a strong founding team that can complement skills and share the passion towards the mission. Secondly, it is important to keep the end-users at the centre of everything and to work closely with healthcare providers to ensure the solution is both usable and valuable. Finally, it is important to be flexible and ready to adapt as market conditions and customer needs change, and to keep the “why” in mind at all times, even during tough moments.

Build a strong founding team, have a bold vision with feasible milestones, keep the end user at the centre, be ready to adapt, and always remember your why. MedTech startup life in a highly regulated industry is not for the faint of heart, but a reminder of your purpose can help overcome the challenges”, Mari Robert, Founder & CEO, InflaMed.

InflaMed’s journey with MedTech Actuator

The MedTech Actuator Accelerator is Asia Pacific’s industry-led, investor-backed 12-month venture development program for early-stage MedTech, BioTech and HealthTech startups.

InflaMed joined the MedTech Actuator Accelerator Cohort 7 in 2022 with the mission to elevate awareness and care around chronic inflammation. MedTech Actuator Accelerator gives founders access to dedicated industry mentors, experts-in-residence, investors, key industry leaders, suppliers and government support agencies. 

We joined the MedTech Actuator for access to a clinical network as we knew we needed to make those partnerships in order to elevate the research and care around chronic inflammation”.

Since joining the program, InflaMed achieved some significant milestones. They have incorporated as an investable company, grown their team from just one person to six, and continued usability testing with their iOS app, which serves as an unregulated, self-managed endpoint. Additionally, they have run market validation with over 100 people for B2B expansion and are working closely with the technology partners on B2B architecture design and prototype development. Lastly, they are ready to raise funds in February 2023.

One of the most beneficial aspects of the MedTech Actuator Accelerator is the exposure to the ecosystem of healthcare innovation. InflaMed utilised the Accelerator experience to connect with other startups, investors, potential partners, government personnel, researchers, and clinicians. They were able to access mentorship from experienced individuals in the industry who have made significant contributions to their work. 

  • Ray Yamamoto Hilton, serving as the Technology Advisor, has been a valuable weekly sounding board and has been instrumental in the design of the architecture in collaboration with Google engineers. He will be transitioning to the role of Chief Technical Officer.
  • Dr Ellen Paton has been thorough in her analysis of clinical workflow and has played a crucial role in defining gaps and refining requirements. The team looks forward to continuing their close collaboration with her.
  • The team would also like to acknowledge the valuable contributions of Dr John Knight, who has served as an excellent mentor with extensive experience in clinical product commercialisation. 
  • Dr. Maida Affan has been instrumental in raising brand awareness and improving social media engagement.

InflaMed recommends joining the Accelerator program.

MedTech Actuator can provide access to essential resources and knowledge for starting a company in the Medical and health industries for determined and resilient founders.”

 

Join MedTech Actuator’s 8th Accelerator cohort

Are you looking to take your health innovation to the next level? 

Applications are open until March 3 for the next Accelerator cohort! Join early-stage healthcare startups in a 12-month accelerator program, tailored to MedTech, HealthTech and BioTech innovation in Australia and Asia Pacific. With investment and access to over 150 industry experts, the MedTech Actuator Accelerator will help to strengthen your commercialisation strategy as you advance your technology closer to the market.

Sign up to receive the Accelerator information pack or schedule a call with Makenzie to discuss the application and see if MedTech Actuator Accelerator is right for you!

MedTech Actuator Accelerator is supported by the REDI initiative, powered by MTPConnect, funded by the MRFF and LaunchVic.



Symex Labs: Enhancing Fertility Outcomes with Wearable Lab-on-a-Chip Technology

MedTech Actuator startup, Symex Labs is revolutionising the fertility industry. The venture is developing lab-on-a-chip solutions that provide continuous monitoring of hormones in interstitial fluid (ISF). The goal is to provide couples who are trying to conceive with a more convenient and effective solution to predict ovulation and measure fertility hormones. The idea has garnered strong market appeal, after extensive market research with Virtus Health, Monash IVF Group and internationally with IVF clinics in the US and Singapore.

The idea behind Symex Labs stemmed from the unpleasant personal experiences of the cofounders’ partners when trying to fall pregnant using the consumer-based products available for ovulation prediction. These products are usually urinary-based, require strict compliance for accurate estimation and involve a cumbersome user experience. This led the co-founders to imagine a “set-and-forget” solution inspired by the prominent Continuous Glucose Monitors (CGM), which are used by diabetic patients to monitor their glucose levels.

Symex Labs’ wearable lab-on-a-chip solution that provides continuous monitoring of hormones in interstitial fluid (ISF).

Driven by passion to help

The disappointment, sadness, and physical and emotional pain that couples experience during unsuccessful IVF rounds drive the team at Symex Labs every day. Cofounders Edgar Charry and Muhammad Umer are passionate about finding solutions that can help couples fall pregnant more easily and reduce the traumatic experience of infertility. Symex Labs is on a mission to achieve more insights into women’s fertility hormones with the sensor they are developing.

Symex Labs is a young company that has carried out extensive market research and its focus is now on the development of its product. Although the technology ecosystem has a great pool of technical talent, some parts of their technology require complex biochemistry and microfluidics design experience, making it challenging to find the right people locally. To overcome this challenge, the team reached out to their network of professionals overseas in the US, Europe and Asia to connect with the right people with the appropriate level of experience.

Symex Labs advises MedTech, HealthTech, or BioTech startups to firstly, do diligent and comprehensive market research before investing too much time in the technology. Secondly, gather feedback from the market as soon as possible. Give mock-ups and prototypes to potential customers to start getting feedback quickly to iterate. Thirdly, de-risk the high-risk parts of the technology as soon as possible. Finally, be ready to pivot if the market is telling you differently from what you originally thought.

It is important to keep in mind the possibility of pivoting – if the market is not interested in your idea, use your technology as a platform to carefully pivot to another area where there’s evidence of more commercial interest in your products and services”, Edgar Charry, CEO & Co-Founder, Symex Labs

Symex Labs is on a mission to revolutionize the fertility industry with their lab-on-a-chip solutions. Their passion for helping couples fall pregnant and their determination to overcome challenges make them a company to watch in the coming years.

Experience with the MedTech Actuator

The MedTech Actuator Accelerator is Asia Pacific’s industry-led, investor-backed 12-month venture development program for early-stage MedTech, BioTech and HealthTech startups.

Symex Labs joined the MedTech Actuator Accelerator Cohort 7 in 2022. The Accelerator experience provided Symex Labs with valuable networking opportunities with IP consultants, business executives, investors, and global medtech partners. The seed funding received through the program allowed the company to acquire lab space, build a small team of experts in biochemistry, immunoassay, and microfluidic research, license proprietary technology from RMIT University. The team has set a goal to create a benchtop prototype by June 2023 to demonstrate the key components of their technology.

Throughout the Accelerator program, founders have access to dedicated industry mentors, experts-in-residence, investors, key industry leaders, suppliers and government support agencies. 

Mentors such as Graham McLean (ex-president Asia Pacific Stryker) and Dr Buzz Palmer (CEO Medtech Actuator) have played a significant role in Symex’s success, providing valuable guidance and support. Participating in the MedTech Actuator cohort 7 has also been enjoyable, as the team had the opportunity to interact with other startups in the medical device industry.

Symex Labs would highly recommend the MedTech Actuator to others in the medical device industry. The networking opportunities and mentorship provided through the program can be invaluable in helping startups grow and progress their business.

There are many ways that you could benefit from participating in the Accelerator program depending on what stage your company is at. For us, networking with important professionals in this ecosystem was vital to grow and progress our business in the right direction”, Edgar Charry, CEO & Co-Founder, Symex Labs.

Join MedTech Actuator’s 8th Accelerator cohort

Are you looking to take your health innovation to the next level? 

Applications are open until March 3 for the next Accelerator cohort! Join early-stage healthcare startups in a 12-month accelerator program, tailored to MedTech, HealthTech and BioTech innovation in Australia and Asia Pacific. With investment and access to over 150 industry experts, the MedTech Actuator Accelerator will help to strengthen your commercialisation strategy as you advance your technology closer to the market.

Sign up to receive the Accelerator information pack or schedule a call with Makenzie to discuss the application and see if MedTech Actuator Accelerator is right for you!

MedTech Actuator Accelerator is supported by the REDI initiative, powered by MTPConnect, funded by the MRFF and LaunchVic.




TuCann Medical’s PIVC: Improving IV Cannula Safety and Patient Experience

MedTech Actuator Accelerator startup, TuCann Medical, is developing a Peripheral Intravenous Cannula (PIVC) that aims to prevent bloodstream infections, phlebitis and occlusion of these devices. Current cannulas used in hospitals have a high rate of complications and often need to be removed, resulting in multiple needle sticks for patients. TuCann Medical’s PIVC aims to change this by creating a safer patient experience where only one line is needed, every time.

The idea for TuCann Medical came about after co-founders, Dr. Maryam Soomro, Santiago Beltran Diaz and Kenneth Wong, realised that the sterility of peripheral IVs is often broken and is a major cause of sepsis and other infections in hospitals. They decided to tackle this problem by designing a PIVC that requires less needle sticks and has novel antimicrobials to prevent infections. As a result, TuCann Medical’s innovation prioritises patient vascular health and comfort, whilst reducing waste and saving time in clinical workflows.

The team is driven by the desire to improve the patient experience and to create a safer environment for patients in hospitals. TuCann Medical’s PIVC has the potential to make a significant impact on healthcare outcomes, reducing the number of deaths caused by sepsis and other infections.

The biggest challenge that the team has faced so far is growing as a startup and as individuals. Starting a company is a journey that requires a lot of growth and self-discovery. The co-founders have found that the biggest challenge is not only the company obstacles faced, but also managing this amongst the opportunities to grow and become better individuals.

“Make sure you are with the right people. Building a strong team is essential for the success of any startup, and the right team can make all the difference in achieving your goals”, Dr Maryam Soomro, CEO, TuCann Medical.

Experience with the MedTech Actuator

TuCann Medical team joined the Accelerator Cohort 5 in 2020.

The MedTech Actuator Accelerator is Asia Pacific’s industry-led, investor-backed 12-month venture development program for early-stage MedTech, BioTech and HealthTech startups. The program will simultaneously accelerate your technology development, build your team capability and provide access to investment. 

The Accelerator is designed to support every dimension of health innovation commercialisation, with elements of the program built to support each cofounder in their focus areas. In 2020, TuCann Medical joined the Accelerator Cohort 5 and used this opportunity to take their PIVC innovation to the next level.

“When I joined the MedTech Actuator, I was hoping to achieve several things. I wanted to gain access to extensive networks in the Australian startup space and to expertise of experienced mentors who could help guide me through the commercialisation process. I also wanted to improve my commercialisation skills, which I intend to carry forward into my startup,” Dr Maryam Soomro, CEO, TuCann Medical.

Throughout the program, founders have access to dedicated industry mentors, experts-in-residence, investors, key industry leaders, suppliers and government support agencies. 

“The mentors I met through the program, Toby McSweeney, Byron Darroch and Greg Rogers, were invaluable in helping me grow TuCann Medical. They helped us identify gaps in our commercialisation strategy and provided guidance on how to fill them”.

The MedTech Actuator Accelerator is designed for maximum speed and efficiency. The program sets milestones for each startup that helps them get to market faster. Startups are surrounded by all the expertise, resources, and infrastructure the healthcare startup needs so founders can focus on building the company.

During the program, TuCann Medical was able to connect with other startups on similar journeys and built a community of support, where they were able to share experiences and learn from one another. Since the Accelerator, TuCann Medical has achieved several milestones accelerating their health innovation to market, including:

  • Incorporation as a company whilst participating in the program, and since then have grown into a seed-stage company with incredible traction in trials, R&D and are moving closer to regulatory approval; 
  • Have negotiated exclusive licensing agreements with RMIT, where they are working on a functioning prototype that we are putting in for FDA assessment;
  • Participated in US-based Techstars and have built out their US networks;
  • Established ties with Monash Health and are negotiating trial agreements;
  • Closed a pre-seed capital raise (America and Australia) and are currently raising a seed round;
  • Have mapped out reimbursement strategies and built a board of advisors, including members from Cook Medical and Cochlear.

Join MedTech Actuator’s 8th Accelerator cohort

“The most beneficial aspect of the MedTech Actuator Accelerator is the lean commercialisation thinking it has, which was really excellent for strategising pathways forward and exit options. I would absolutely recommend the MedTech Actuator to others. It is vital to fill in the commercialisation gaps of the science-heavy start-ups and spin-offs in this space. The MedTech Actuator Accelerator is an incredible program that provides a wealth of resources, networks and mentorship to help young start-ups grow and succeed in the MedTech industry.”

Are you looking to take your health innovation to the next level? 

Applications are open until March 3 for the next Accelerator cohort! Join early-stage healthcare startups in a 12-month accelerator program, tailored to MedTech, HealthTech and BioTech innovation in Australia and Asia Pacific. With investment and access to over 150 industry experts, the MedTech Actuator Accelerator will help to strengthen your commercialisation strategy as you advance your technology closer to the market.

Sign up to receive the Accelerator information pack or schedule a call with Makenzie to discuss the application and see if MedTech Actuator Accelerator is right for you!

MedTech Actuator Accelerator is supported by the REDI initiative, powered by MTPConnect, funded by the MRFF and LaunchVic.

Announcing MedTech Actuator Showcase 2022 Award Winners

At the recent MedTech Actuator Showcase, we joined ecosystem leaders to celebrate Asia Pacific’s next wave of early-stage MedTech, HealthTech and BioTech entrepreneurs – with four taking home prestigious awards.

About MedTech Actuator Entrepreneurs

Our changemakers are taking their innovations further and faster with MedTech Actuator programs. Eight teams took to the stage in Melbourne to pitch to the ecosystem and industry leaders, including the largest names in medical technology and the startup ecosystem.

Stepping into the spotlight were entrepreneurs from early-stage innovation programs including MedTech Actuator Origin Australia and Japan and MedTech Actuator’s flagship Accelerator program.

Award Winners

MinterEllison MedTech Actuator Origin 2022 Award: EN∀I

Dr Simone Mitchel, Partner at MinterEllison joined us to announce the MinterEllison MedTech Actuator Origin 2022 Award.

Congratulations to Amin Abbas from ENI on taking out this prestigious award after a highly competitive process and pitching at the finals. EN∀I was selected by the audience and judges as the winner out of four early-stage entrepreneurs who made it to the Origin finals.

EN∀I is improving endometriosis imaging by using ultrasound with inbuilt guidance and 3D reconstruction.

“We were really impressed with the pitches tonight and we decided to offer the winner another $10k in in-kind legal services. Congratulations, EN∀I”, – Dr Simone Mitchel, Partner, MinterEllison.

As the MinterEllison MedTech Actuator Origin 2022 Award winner, ENI receives an AUD$10K cash prize, over AUD$5K worth of in-kind support from MedTech Actuator, legal services from MinterEllison to the value of AUD$10K, as well as access to a fast-tracked entry into the MedTech Actuator Accelerator 2023. 

MinterEllison MedTech Actuator Origin 2022 Award winners: Team EN∀I with Buzz Palmer, CEO MedTech Actuator and Simone Mitchel, Partner Minter Ellison

Bupa MedTech Actuator Accelerator 2022 Award: Anura Medical

Gerald Marion, Chief Customer and Strategy Officer at Bupa Asia Pacific, joined us to present the Bupa MedTech Actuator Accelerator 2022 Award. 

“Congratulations to the winner – innovations require a lot of perseverance and it is a long journey to market”, – Gerald Marion, Chief Customer and Strategy Officer, Bupa Asia Pacific.

The MedTech Actuator Accelerator supports founders in taking their innovation from Seed to Series A. Embedded in the MedTech Actuator ecosystem, startups radically advance their technology development, raise pre-seed capital, gain critical business and management skills and build a comprehensive commercialisation strategy. 

Congratulations to every founder on their relentless execution towards market success over these past six months – and to Phoebe Lewis from Anura Medical who took home the Bupa MedTech Actuator Accelerator 2022 Award, winning an AUD$10K cash prize.

Anura Medical helps people breathe better through continuous, wearable lung monitoring.  Founded by a team of engineers, doctors, and business consultants, Anura aims to create a new gold standard that will enable clinicians to treat breathing decline early and reduce health complications for people with lung disease.

Bupa MedTech Actuator Accelerator 2022 Award winner: Team Anura Medical with Buzz Palmer, CEO MedTech Actuator and Gerald Marion, Chief Customer and Strategy Officer, Bupa Asia Pacific.

MedTech Actuator People’s Choice 2022 Award: Vysum

Congratulations to MedTech Actuator Accelerator participant, Lorace Zhang from Vysum, for being selected for the MedTech Actuator People’s Choice 2022 Award.

MedTech Actuator Showcase guests from the innovation ecosystem – spanning investor groups and VCs, multinational corporations, hospitals, product development firms, universities, and research institutes – voted for their favourite pitch of the night, with Vysum taking home the prize.

This coveted vote of confidence went to Vysum for enabling easier eye drop delivery and glaucoma management. Vysum takes home an AUD$1K cash prize.

MedTech Actuator People’s Choice Award winner Lorace Zhang with Buzz Palmer, CEO MedTech Actuator and Rebecca Davies AO, MedTech Actuator Board Member

CROW Clinical Emerging Female Founder 2022 Award: April Van Der Kamp

In 2022, MedTech Actuator focused its efforts to help bridge the gaps for female and diverse founders to pursue entrepreneurship. In its first year event, Julie Von Grum, Director at CROW Clinical, joined to present the CROW Clinical Emerging Female Founder 2022 Award.

Now is the time for women to step up, to have a voice and confidence to go out start new ventures and raise capital”, Julie Von Grum, Director, CROW Clinical.

The CROW Clinical Emerging Female Founder 2022 Award was presented to April Van Der Kamp, CEO, DFU Solutions, acknowledging the impact and progress she has made as a leading female founder and CEO in the space. This award comes with an AUD$10K cash prize to recognise her contribution and efforts as an extraordinary female founder in our community. 

April started her journey with MedTech Actuator as a MedTech Actuator Menzies Scholar in 2021 before embarking on her journey in the MedTech Actuator Accelerator 2022 as the CEO of DFU Solutions, a BioTech startup developing safe, effective, convenient bacteriophage-based treatments for infected wound care.

Read more on April’s experience with the MedTech Actuator programs. Congratulations April, you inspire all the women in STEMM!

CROW Clinical Emerging Female Founder 2022 Award winner: April Van Der Kamp with Julie Von Grum, Director, CROW Clinical

It Takes A Village to Raise a MedTech Startup

The MedTech Actuator Showcase and the specialised acceleration model underpinning all of our programs would not be possible without the support of the innovation ecosystem. Read more about the evening and sponsors in the event brochure.

Special guests

Thank you to our distinguished Showcase guests for your support of our MedTech superheroes and the ecosystem:

  • Mr. Yasuyuki Murahashi – Director-General, JETRO Osaka
  • Rebecca Davies AO – MedTech Actuator Board Member; Director, Heart Foundation
  • Michelle Gallaher – MedTech Actuator Board member; CEO – Opyl

and others.

Showcase Sponsors

We would like to acknowledge our Gold and Bronze Sponsors for the MedTech Actuator Showcase – thank you to:

  • MinterEllison
  • Bupa
  • CROW Clinical
  • Hydrix
  • Biodesign Australia
MedTech Actuator Showcase 2022 Sponsors

Partners

We would also like to thank our Foundation and Product Development partners for their constant and continued support of both the MedTech Actuator and the ecosystem.

Friends and supporters

A very special shoutout to all our ecosystem friends and supporters. Without you, we would not be able to surround founders with the support they need to bring innovations to the patients and clinicians who need it most.

MedTech Actuator Accelerator applications are now open for 2023!

Do you have a medical innovation that you’re ready to bring to market? MedTech Actuator’s Accelerator is here to help and expression of interest is open. Over 12 months, the program will equip your team with the skills, network and resources needed to successfully navigate the commercialisation pathway. Become a part of MedTech Actuator’s next Accelerator cohort!

MedTech Actuator Origin and Accelerator are supported by the REDI initiative, powered by MTPConnect, funded by the MRFF and LaunchVic.

MedTech Actuator Origin Japan 2022 is sponsored by JETRO and co-organized with JETRO, OCCI and OBDA.

MedTech Actuator Showcase 2022 Lineup Announced

The annual MedTech Actuator Showcase brings together leaders and representatives from both the Australian and global health innovation ecosystems. The night will connect and celebrate the achievements, impact and progress of MedTech Actuator entrepreneurs and founders.

At the Showcase, MedTech Actuator Origin and Accelerator Cohort 7 startups will pitch to an audience of over 300 individuals to win $30,000+ in prizes across 4 categories. This event will also feature inspiring speeches from industry leaders, an insightful fireside chat with fast-growing MedTech startups, and opportunities to connect with ecosystem stakeholders.

Meet the four MedTech Actuator Accelerator startups pitching

MedTech Actuator’s flagship 12-month Accelerator program annually selects health startups investing up to  $200,000 in equity-based funding. The program encourages access to over 200 industry experts from across Australia and the globe, to accelerate their growth towards the market. 

At the showcase, hear from four Cohort 7 Accelerator startups innovating in phage therapy,  respiratory function, lumbar punctures and eye drop delivery.

Anura Medical Enabling preventative health care through innovative lung monitoring. 

DFU Solutions Improving outcomes for diabetic foot ulcer patients.

Vause Medical An accessible improvement to lumbar punctures in newborns

Vysum Enabling easier eye drop delivery and glaucoma management.

Meet the four MedTech Actuator Origin Finalists

MedTech Actuator Origin is an early-stage innovation program that turbocharges the development of emerging human health technologies and solutions across Australia and Asia-Pacific. 

32 Qualifying teams joined MedTech Actuator in Melbourne for an intensive sprint, where, over three days, they learned from industry experts, pressure tested their innovations, networked with a cohort, gained exposure to the startup ecosystem and health innovation, and pitched at the semi-finals. 4 Origin finalists innovating in dental, IVF,  dermatitis and endometriosis we selected in the semifinals.

AcuDent AcuDent is developing a medical device to revolutionise the detection of severe gum disease.

ENVI ENVI is improving endometriosis imaging by using ultrasound with inbuilt guidance and 3D reconstruction.

Innova IVF Innova IVF is creating simple, affordable chip technology to measure the energy of embryos in real time for IVF treatments.

Osaka Heat Cool Osaka Heat Cool helps to tackle the symptoms of Atopic Dermatitis (AD), allergies, and other skin diseases by stopping itchiness using thermal illusion on the skin.

At the Showcase, an exclusive black-tie event, 300+ senior representatives from 30+ key ecosystem organisations including governments, global corporations, universities, product development and startup support companies, and the inspiring health innovators, startup entrepreneurs and future stars of the Asia-Pacific health ecosystem will come together to showcase the MedTech startup ecosystem.

Join us at the MedTech Actuator Showcase and experience the power of the global MedTech ecosystem here in Melbourne. If you are interested in attending or sponsoring the event, please reach out to Matthew Frith, Chief Commercial Officer at MedTech Actuator.

MedTech Actuator Origin and Accelerator are supported by the REDI initiative, powered by MTPConnect, funded by the MRFF and LaunchVic.

Congratulations to the MedTech Actuator Origin 2022 Finalists!

Out of thirteen impressive startups that made it to the Origin Semi-final, MedTech Actuator is proud to announce four finalists moving forward to pitch at the MedTech Actuator Showcase in December.

After three days of intensive workshops, 10 emerging founders took to the stage to pitch in the 2022 MedTech Actuator Origin Semi-finals. Amongst the Australian founders, three Semi-Finalists from Origin Japan also joined the program in Melbourne, where they learned from industry experts, pressure-tested their innovations, and explored Australia’s startup ecosystem. 

Tackling some of the biggest challenges in healthcare, Finalists are innovating across dental, IVF, itching and endometriosis. Meet the MedTech Actuator Origin 2022 Finalists:

AcuDent

Team members: Liam Murray, Aaron Binns, Anna Dai, Ashwin Ho, Ivy Weng 

AcuDent is developing a medical device to revolutionise the detection of severe gum disease.

AcuDent’s device, the AcuProbe, applies computer vision within the oral environment to more efficiently and accurately conduct the work that current practice burdens the clinician to do manually. The device will ensure that proper diagnosis is achieved to avoid the occurrence of undetected periodontitis, ensuring patients receive the best possible care and dramatically reducing the chances of tooth loosening and tissue degradation – keeping everyone smiling longer.

ENVI 

Team members: Amin Abbas, Nay Minn, Dr Rizwan Jaipurwala, Frederick Lau, Joey Zhou, Steven Wong

ENVI is improving endometriosis imaging by using ultrasound with inbuilt guidance and 3D reconstruction.

ENVI is working on creating a device that can diagnose endometriosis using ultrasound. The device aims to reduce the diagnostic duration for endometriosis. This allows patients to receive an early diagnosis and hence access to early treatment.  Early diagnosis gives patients hope of slowing disease progression and reduces the harmful long-term risks associated with endometriosis, including its association with an increase in cancer risk. It also benefits GPs by reducing multiple patient visits with undifferentiated symptoms, improving the workflow of primary care staff and increasing patient satisfaction. 

Innova IVF

Team members: Dr Fabrizzio Horta, Dr Victor Cadarso, Prof Adrian Neild, Prof Beverley Vollenhoven, A/Prof Sally Catt

Innova IVF is creating simple, affordable chip technology to measure the energy of embryos in real time for IVF treatments.

Innova IVF aims to improve treatments for couples suffering from infertility worldwide. The most critical aspect of IVF treatments relies on the selection of embryos that will lead to a healthy live birth. Thus, the team aims to improve embryo selection by introducing novel non-invasive technology to measure the embryo’s energy in the form of metabolic activity.

Osaka Heat Cool

Team members: Kenzo Ibano, Kiyono Yoshikuni, Toru Sugahara, Kuichi Itoh, Katsunari Sato, Shintaro Izumi 

Osaka Heat Cool helps to tackle the symptoms of Atopic Dermatitis (AD), allergies, and other skin diseases by stopping itchiness using thermal illusion on the skin.

The team is solving the pain caused by itching using thermal illusion on the skin. Using an illusion called the thermal grill illusion, the device provides pain sensation by applying hot and cold sensations simultaneously. This pain sensation does not harm the skin, instead relieves the itch without scratching by nails.

We would like to thank our judges Dr Buzz Palmer, CEO of MedTech Actuator, Lorace Zhang, CEO at Vysum and MedTech Actuator Origin 2021 Winner, Laxmi Pun, Director of Early-stage Investments at Breakthrough Victoria, Shanna Lam, Project Officer at MedTech Actuator, and all community members for attending the MedTech Actuator Origin Semi-final and cheering on startups improving health outcomes.

The MedTech Actuator Origin Final will take place on Thursday, December 1 at the MedTech Actuator Showcase. At the Showcase, teams will have the chance to take home a $10K cash prize, over $5k worth of in-kind support and gain access to fast-tracked entry into MedTech Actuator Accelerator 2023.

What is next?

Preparations are now underway for a night-of-nights celebration at the MedTech Actuator Showcase, where all programs converge and the ecosystem – from across the Asia-Pacific – will come together to applaud the achievements, impact and progress of founders in health innovation. 

The MedTech Actuator Showcase will be held on Thursday, December 1 in Melbourne. If you are interested in purchasing a table or sponsoring a prize for this exclusive event, please reach out to Matthew Frith, Chief Commercial Officer at MedTech Actuator.

Stay in the loop by signing up for our newsletter below to get the latest updates on our programs and upcoming events.

MedTech Actuator Origin is supported by the REDI initiative, powered by MTPConnect, funded by the MRFF and LaunchVic.



From fighting cancer to founding ChezLeon: Cheryl Pollock’s story

October is Breast Cancer Awareness month and MedTech Actuator would like to acknowledge the impacts of breast cancer and the importance of creating awareness about it. 

MedTech Actuator startups work to improve and save the lives of people through health innovation. This month we are shining a light on ChezLeon, a MedTech Actuator startup that designs & manufactures patented DP-TX Massage Wear that helps relieve pain and reduce swelling from fluid blockages. Fluid blockages can be caused by a wide range of conditions including lymphoedema, mastitis, oedema, heart & vascular conditions, major surgery, injuries and post-breast cancer treatment. By treating the blockage rather than the swelling, DP-TX products help patients regain their freedom and quality of life.

The journey from fighting cancer to founding ChezLeon

 Cheryl Pollock came up with the idea for her startup ChezLeon after going through cancer treatment and dealing with lymphoedema herself. 

After undergoing cancer treatment involving the removal of all my lymph nodes in both groins, I started to experience pain and swelling caused by the blockage to the lymphatic system.  I tried everything on the market and found that the current treatments were unsatisfactory and were causing more issues”, Cheryl Pollock, CEO and Founder of ChezLeon Pty Ltd.

With a background in mechanical engineering, construction and studying remedial massage and the lymphatic system, she realised that the current treatments were not addressing the problem which is the blockage caused by the surgery and lymph node damage.

The current treatments for lymphoedema focused on the outcome – the swelling; they were not suitable for everyone, particularly in the hot Australian climate. Using her engineering skills, Cheryl designed a clothing insert using differential pressure to gently massage the site of the blockage providing immediate relief. ChezLeon DP-TX massage bra inserts for Breast Cancer, gently massage the area of the blockage, helping to break down scar tissue and to move the fluid around the blockage. It helps drain the limbs or prevent build-up in the limb or associated area. Soon Cheryl was approached by other patients suffering from various fluid blockage conditions asking for help. Seeing patients dealing with pain and swelling for several years and finding immediate relief by wearing the product is what drove Cheryl to do more. 

“I was able to help women with golf-ball size swelling and pain due to lymphoedema lead a pain-free life with the ability to return to work and regain their quality of life”, adds Cheryl.

ChezLeon DP-TX massage inserts

Bringing the product to market

The startup journey has been challenging for ChezLeon, particularly in finding a manufacturer, and a supportive community. Existing manufacturers were reluctant due to a lack of capability and skills. After spending months finding the right manufacturer locally, in the end, ChezLeon had to rely on outsourcing manufacturing for the product.

Being a solo female founder in her 60s, it has been a hard road to find funding for ChezLeon. Due to the nature of its product, bridging the funding gap between the Minimum Viable Product (testing) to commercialisation (market launch) has been complicated due to the costs involved. 

In spite of these challenges, ChezLeon is breaking through these barriers and making significant progress in bringing high-impact health products to market. Cheryl advises startups on a similar path to focus on their passion and the impact their product can have on patients when facing difficult times in their commercialisation journey.

I started as a patient and then worked with patients gaining a real understanding of what they were experiencing and what they wanted.  I developed my products with and for the patients.  They gave me the passion and determination to get through hard times, they picked me up and kept me going.  Being a medical start-up is one of the most difficult paths to go down. Without passion and people to motivate you, it would be extremely difficult. Deeply understand what your patients need by listening to their pain and addressing the cause; you will find helping them the most rewarding and grateful experience”.

MedTech Actuator Accelerator Experience 

 ChezLeon joined MedTech Actuator Accelerator Cohort 5 in 2020 with the hope to gain networking, support and funding opportunities. Since then ChezLeon has been able to get private investment and get sample runs manufactured and trialled with hospitals such as Liverpool &  Campbelltown Hospitals, GenesisCare – Gold Coast, Breast Cancer Physio-Gold Coast and Oncology Recovery Service-Sydney. The company is also engaged in the planned clinical study of head and neck Lymphoedema at  Mater Hospital Newcastle.

“I recommend joining the MedTech Actuator Accelerator early to set the foundation and map out the pathway as this will save a lot of time and energy in the long run. The MedTech Actuator gives you a great foundation to navigate the difficult pathway through the development of medical products. Their connections and networks give you access to specialists in their particular field worldwide so you get the latest information from the source”, Cheryl.

Cheryl at the MedTech Actuator’s Morning with Women in Health Entrepreneurship event.

Breast Cancer Awareness

Chery Pollock, CEO and Founder, ChezLeon Pty Ltd

“Everyone’s cancer journey is different. From my experience, going through cancer treatment is very scary, as you go through a range of emotions. It’s as if life stands still, nothing matters except your family and getting through this. Then you are told that due to the treatment you could end up with lymphoedema, a debilitating swelling of a limb/s with no cure. ‘You have just survived a death sentence only to be given a life sentence’. 

As with cancer, early detection is the key to a successful outcome, the same applies to lymphoedema. Early intervention, and taking a preventative approach help with the long-term management of fluid build-up. As it can take from 3 to 30 years for swelling to develop enough to be diagnosed, patients need to take a proactive approach to manage their condition from day one.  From breaking down scar tissue to encourage lymph growth and strengthening lymphatic pathways to self-massage, exercise, skincare and deep breathing.  Also understanding their condition, their body and what works for them.  There is no miracle cure, no one-off treatment, it is a condition that has to be managed for the rest of your life therefore any treatment has to be maintained.  The most important thing is to have a positive attitude, have some fun and laugh as often as possible.  This not only helps you but also those around you who are on the journey with you”, Cheryl on breast cancer awareness. 

Learn more about the lymphatic system, lymphoedema and how to manage it on ChezLeon’s website and follow their journey as they create awareness about Breast Cancer.

Expression of interest is now open for MedTech Actuator Accelerator 2023.

The MedTech Actuator Accelerator is supported by the REDI initiative, powered by MTPConnect, funded by the MRFF and LaunchVic.